معرفی
Olivier Feron is a Professor at Université catholique de Louvain (UCLouvain) in the Faculty of Medicine, Department of Cellular and Molecular Medicine. With an h-index of 17 and 26 research outputs spanning from 2007 to 2022, his work focuses on critical aspects of cancer biology. He has served as Co-Investigator on significant research projects including THERAPLUS (2014-2017), which investigated proton therapy combined with gold nanoparticles for tumor treatment.
Dr. Feron's research interests center on the complex interplay between tumor microenvironment and cancer progression. His work explores how hypoxia, inflammation, and metabolic alterations influence tumor behavior, particularly in relation to metastasis. He has made significant contributions to understanding how cycling hypoxia affects macrophage behavior and promotes inflammatory responses within tumors. His research also investigates the role of lipid metabolism in cancer cell migration and metastatic spread, as well as potential therapeutic applications of compounds like disulfiram in targeting cancer metabolism.
Analysis of his recent publications reveals a strong focus on tumor microenvironment dynamics, particularly the relationship between hypoxia, inflammation, and metastasis. His work bridges basic cancer biology with potential therapeutic applications, as evidenced by his research on omega-3 fatty acids as tumor-targeting agents and the repurposing of disulfiram for cancer treatment. The interdisciplinary nature of his research connects immunology, metabolism, and cell signaling pathways in cancer.
Dr. Feron has been actively involved in science communication, with 20 media appearances including expert commentary on his research regarding omega-3 fatty acids' effects on tumors. His work has received significant attention, with publications picked up by 9 news outlets, blogged about by 3 sources, and shared across social media platforms with thousands of engagements.
As a supervisor, Dr. Feron has guided 4 students through their research work. He is also actively involved in the International Society of Cancer Metabolism, having co-authored proceedings from their annual meeting. His research contributes to UN Sustainable Development Goals related to good health and well-being through advancing cancer treatment approaches.
